Agnes Bosch
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Universitätsklinikum Erlangen(DE)Comprehensive Cancer Center Erlangen(DE)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Diabetes Treatment and Management, Cardiovascular Health and Disease Prevention, Cardiovascular Function and Risk Factors, Retinal Imaging and Analysis
Most-Cited Works
- → SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial(2018)180 cited
- → How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial(2019)118 cited
- → Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure(2021)65 cited
- → The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial(2022)57 cited
- → Retinal capillary rarefaction in patients with untreated mild-moderate hypertension(2017)53 cited
- → Tissue sodium content in patients with type 2 diabetes mellitus(2019)34 cited